Urocit-k and Ms contin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Urocit-k (potassium citrate) and Ms contin (morphine sulfate). Common drug interactions include anxiety among females.

The phase IV clinical study analyzes what interactions people have when they take Urocit-k and Ms contin. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Urocit-k?

Urocit-k has active ingredients of potassium citrate. It is often used in kidney stones. eHealthMe is studying from 708 Urocit-k users. Check the latest studies of Urocit-k.

What is Ms contin?

Ms contin has active ingredients of morphine sulfate. It is often used in pain. eHealthMe is studying from 69,289 Ms contin users. Check the latest studies of Ms contin.



On Jul, 31, 2026

31 people who take Urocit-k and Ms contin together, and have interactions are studied.

Urocit-k and Ms contin drug interactions.

What are the common drug interactions of Urocit-K and Ms Contin, by gender? *:

female:

  1. Anxiety
  2. Arthralgia (joint pain)
  3. Eye pain
  4. Facial bones fracture (bone fracture of face)
  5. Fall
  6. Femur fracture
  7. Glossitis (infection of tongue with soreness)
  8. Groin pain
  9. Haemolytic anaemia (anaemia due to haemolysis)
  10. Hand fracture

male:

n/a

What are the common drug interactions of Urocit-K and Ms Contin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Dizziness
  2. Dry mouth
  3. Emotional distress
  4. Eye infection
  5. Eye pain
  6. Facial bones fracture (bone fracture of face)
  7. Fall
  8. Femur fracture
  9. Glossitis (infection of tongue with soreness)
  10. Groin pain

60+:

  1. Abdominal pain
  2. Acquired oesophageal web (structural abnormalities in the oesophagus)
  3. Bruxism (habitual grinding of the teeth, typically during sleep)
  4. Cardiac failure congestive
  5. Carditis (infection of heart and surrounding)
  6. Cellulitis (infection under the skin)
  7. Chest pain
  8. Chest wall mass
  9. Chondromalacia (anterior knee pain due to irritation of the cartilage on the under surface of the kneecap)
  10. Chronic sinusitis (long lasting inflammation of the paranasal sinuses)

What are the existing conditions these people have? *

  1. Breast Cancer: 8 people, 25.81%
  2. Osteoporosis (bones weak and more likely to break): 4 people, 12.90%
  3. Multiple Myeloma (cancer of the plasma cells): 4 people, 12.90%
  4. Metastases To Bone (cancer spreads to bone): 4 people, 12.90%

* Approximation only. Some reports may have incomplete information.

Do you take Urocit-k and Ms contin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Urocit-k and Ms contin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Urocit-k:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ms contin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Urocit-k and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ms contin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on potassium citrate and morphine sulfate (the active ingredients of Urocit-k and Ms contin, respectively), and Urocit-k and Ms contin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: